Drug development output: what proportion for tropical diseases?

被引：15
作者：
Trouiller, P
Olliaro, PL
机构：
[1] CHU Grenoble, F-38043 Grenoble 9, France
[2] WHO, UNPD, World Bank, Special Programme Res & Training Trop Dis, Geneva, Switzerland
来源：
LANCET | 1999年 / 354卷 / 9173期
关键词：
D O I：
10.1016/S0140-6736(05)75299-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：164 / 164
页数：1
相关论文
共 5 条
[1]   The effect of pharmacoeconomics on company research and development decisions [J].
Grabowski, H .
PHARMACOECONOMICS, 1997, 11 (05) :389-397
[2]   Will the fight against tropical diseases benefit from orphan drug status? [J].
Olliario, P .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (02) :113-115
[3]   Access to essential drugs in poor countries -: A lost battle? [J].
Pécoul, B ;
Chirac, P ;
Trouiller, P ;
Pinel, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (04) :361-367
[4]  
Trouiller P, 1998, Int J Infect Dis, V3, P61, DOI 10.1016/S1201-9712(99)90010-3
[5]  
TROUILLER P, IN PRESS TROP MED IN
1